Mission GBM

In Memoriam

Julie A. Rakestraw is now at peace

Jan 22 • 

Scott L. Rakestraw, PhD

28

August 2024

July 2024

Postcards from the Field

Some green shoots of investing progress as MissionGBM welcomes its 300th case

Jul 30, 2024 • 

Scott L. Rakestraw, PhD

12

Michael Lim, MD – Brain Cancer Science Talk (Episode 7)

Stanford’s Chair of Neurosurgery discusses the promise and challenges associated with immunotherapy for brain tumors

Jul 15, 2024 • 

Scott L. Rakestraw, PhD

6

30:07

The Reality of Clinical Trials – Part 2

Bess Stillman, MD details how the Regulatory process needs to be modernized to better serve both cancer patients and Sponsors. We extend the concepts to…

Jul 2, 2024 • 

Scott L. Rakestraw, PhD

3

June 2024

ASCO 2024: Brain Cancer Highlights

A few potential gems begin to sparkle

Jun 20, 2024 • 

Scott L. Rakestraw, PhD

2

Anniversary Post: 35 Years, 918 Days…and Counting

A Brain Cancer Diagnosis Can Be a Catalyst to Celebrate Life

Jun 10, 2024 • 

Scott L. Rakestraw, PhD

19

David D. Tran, MD, PhD – Brain Cancer Science Talk (Episode 6)

An Open-Minded and Curious Physician/Scientist Follows the #Data to Innovate a Compelling Protocol for Treating Gliomas

Jun 5, 2024 • 

Scott L. Rakestraw, PhD

5

58:11

Glossary of Terms

A Reader-Requested Roadmap of the MissionGBM Abbreviations and Acronyms

Jun 3, 2024 • 

Scott L. Rakestraw, PhD

1

May 2024

Paul S. Mischel, MD – Brain Cancer Science Talk (Episode 5)

ecDNA, the Importance of Science, #Data and Collaboration, and Upgrading Science in Neuro-Oncology

May 30, 2024 • 

Scott L. Rakestraw, PhD

2

43:30

Meet the Team – Paul S. Mischel, MD

World Class Molecular Oncologist, Invaluable Thought Partner and Complete Mensch

May 23, 2024 • 

Scott L. Rakestraw, PhD

6

News: Erasca Reorganizes and Deprioritizes Development of ERAS-801 for rGBM

Yet Another EGFR-targeted Monotherapy Drops Anchor

May 17, 2024 • 

Scott L. Rakestraw, PhD

3